DE69921137T2 - Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster - Google Patents

Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster Download PDF

Info

Publication number
DE69921137T2
DE69921137T2 DE69921137T DE69921137T DE69921137T2 DE 69921137 T2 DE69921137 T2 DE 69921137T2 DE 69921137 T DE69921137 T DE 69921137T DE 69921137 T DE69921137 T DE 69921137T DE 69921137 T2 DE69921137 T2 DE 69921137T2
Authority
DE
Germany
Prior art keywords
formula
gabapentin
use according
hydrogen
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69921137T
Other languages
German (de)
English (en)
Other versions
DE69921137D1 (de
Inventor
Leslie Magnus
A. Catherine SEGAL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE69921137D1 publication Critical patent/DE69921137D1/de
Publication of DE69921137T2 publication Critical patent/DE69921137T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69921137T 1998-07-09 1999-06-18 Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster Expired - Fee Related DE69921137T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9217198P 1998-07-09 1998-07-09
US92171P 1998-07-09
PCT/US1999/013947 WO2000002592A1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles

Publications (2)

Publication Number Publication Date
DE69921137D1 DE69921137D1 (de) 2004-11-18
DE69921137T2 true DE69921137T2 (de) 2006-02-02

Family

ID=22231986

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921137T Expired - Fee Related DE69921137T2 (de) 1998-07-09 1999-06-18 Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster

Country Status (17)

Country Link
EP (1) EP1093366B1 (https=)
JP (1) JP2002520300A (https=)
KR (1) KR20010071776A (https=)
AT (1) ATE279188T1 (https=)
AU (1) AU765246B2 (https=)
CA (1) CA2332929C (https=)
DE (1) DE69921137T2 (https=)
DK (1) DK1093366T3 (https=)
ES (1) ES2230863T3 (https=)
ID (1) ID27395A (https=)
NO (1) NO20010116L (https=)
NZ (2) NZ508489A (https=)
PL (1) PL345337A1 (https=)
PT (1) PT1093366E (https=)
SI (1) SI1093366T1 (https=)
WO (1) WO2000002592A1 (https=)
ZA (1) ZA200007169B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60022333T2 (de) 1999-04-09 2006-07-06 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
IL160523A0 (en) 2001-09-03 2004-07-25 Newron Pharm Spa PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
MX2007006093A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.
KR20160095358A (ko) 2015-02-03 2016-08-11 고려대학교 산학협력단 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9321394D0 (en) * 1993-10-16 1993-12-08 Smihtkline Beecham P L C Pharmaceuticals
WO1997033859A1 (en) * 1996-03-14 1997-09-18 Warner-Lambert Company Novel bridged cyclic amino acids as pharmaceutical agents
IL126999A (en) * 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain

Also Published As

Publication number Publication date
ZA200007169B (en) 2002-03-04
PL345337A1 (en) 2001-12-17
NO20010116D0 (no) 2001-01-08
ES2230863T3 (es) 2005-05-01
DK1093366T3 (da) 2004-12-06
ID27395A (id) 2001-04-05
CA2332929A1 (en) 2000-01-20
JP2002520300A (ja) 2002-07-09
PT1093366E (pt) 2005-02-28
AU4701699A (en) 2000-02-01
SI1093366T1 (en) 2005-02-28
EP1093366B1 (en) 2004-10-13
EP1093366A1 (en) 2001-04-25
NZ525623A (en) 2005-08-26
KR20010071776A (ko) 2001-07-31
AU765246B2 (en) 2003-09-11
NO20010116L (no) 2001-01-08
CA2332929C (en) 2005-05-31
ATE279188T1 (de) 2004-10-15
NZ508489A (en) 2004-06-25
WO2000002592A1 (en) 2000-01-20
DE69921137D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
DE69832712T2 (de) Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen
DE3586545T2 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE69934813T2 (de) Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen
EP1093369B1 (de) Mittel mit antidepressiver wirkung, enthaltend pramipexol und sertralin
CA2333024C (en) Method for the treatment of insomnia
DE69129115T2 (de) Neues verfahren zur behandlung von depression
DE10025946A1 (de) Wirkstoffkombination
DE69621799T2 (de) Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen
WO1997015300A2 (de) Verwendung von 4-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen zur prophylaxe und behandlung der folgen der akuten und chronischen zerebralen minderdurchblutung sowie neurodegenerativer erkrankungen
DE3786893T2 (de) Piperidinderivat zur Schmerzbehandlung.
EP0530446B1 (de) Verwendung von Schwefel enthaltenden Carbonsäuren zur Bekämpfung von pathophysiologisch bedingten Erregungsstörungen
DE60218193T2 (de) Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia
DE3137125C2 (https=)
EP0185210B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE69921137T2 (de) Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster
DE68911273T2 (de) Benzothiazepine zur Herstellung von Medikamenten zur Milderung von epileptischen Anfällen.
DE2525064C2 (de) Arzneimittel mit Antiparkinson-Wirkung
DE69927591T2 (de) Behandlung von nierenkolik mit gaba-analogen
DE3780702T2 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
US20030045500A1 (en) Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
EP1294376A2 (de) Arzneimittel zur bekämpfung von atemdepression
DE3820817C2 (de) Antileptikum
DE2636328A1 (de) Arzneimittel
DE69131521T2 (de) Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee